Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model
Summary
Topical RCI001 showed excellent therapeutic effects in environmental DED models by stimulating tear secretion, modulating oxidative stress and improving corneal epithelial healing compared to 1% PDE and 5% Lifitegrast. © 2024. The Author(s).
| Authors | Jung YH, Ku YA, Moon J, Kim S, Ryu JS, Yoon CH, Chung MH, Kim YH, Kim MK, Kim DH |
|---|---|
| Journal | Eye and vision (London, England) |
| Publication Date | 2024 Jun 1;11(1):19 |
| PubMed | 38822444 |
| PubMed Central | PMC11143567 |
| DOI | 10.1186/s40662-024-00388-z |